The aim of the TINN2 study is to evaluate the efficacy of azithromycin in prevention of
bronchopulmonary dysplasia in preterm neonates.
Phase:
Phase 3
Details
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Collaborators:
Advanced Biological Laboratories ABL (ABL SA) Assistance Publique - Hôpitaux de Paris Cardiff University Centre Hospitalier Chrétien (CHC) Erasmus Medical Center Heinrich-Heine-Universität Düsseldorf (UDUS) Inserm-Transfert (IT) Karolinska Institutet Mario Negri Institute (IRFMN) Only For Children Pharmaceuticals Semmelweis University Simcyp Limited (SimCyp) University of Liverpool University of Nottingham University of Ulm